C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.405 AUD -6.64% Market Closed
Market Cap: 156.1m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Cyclopharm Ltd
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Cyclopharm Ltd
Total Receivables Peer Comparison

Comparables:
R
RSH
IPD
COH
OIL
EMV

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
Cyclopharm Ltd
ASX:CYC
Total Receivables
AU$8.3m
CAGR 3-Years
18%
CAGR 5-Years
19%
CAGR 10-Years
10%
R
Respiri Ltd
ASX:RSH
Total Receivables
AU$253.1k
CAGR 3-Years
23%
CAGR 5-Years
9%
CAGR 10-Years
12%
ImpediMed Ltd
ASX:IPD
Total Receivables
AU$3.2m
CAGR 3-Years
-11%
CAGR 5-Years
-4%
CAGR 10-Years
22%
Cochlear Ltd
ASX:COH
Total Receivables
AU$502m
CAGR 3-Years
11%
CAGR 5-Years
9%
CAGR 10-Years
9%
Optiscan Imaging Ltd
ASX:OIL
Total Receivables
AU$1.6m
CAGR 3-Years
8%
CAGR 5-Years
30%
CAGR 10-Years
9%
EMvision Medical Devices Ltd
ASX:EMV
Total Receivables
AU$2.8m
CAGR 3-Years
N/A
CAGR 5-Years
123%
CAGR 10-Years
N/A

See Also

What is Cyclopharm Ltd's Total Receivables?
Total Receivables
8.3m AUD

Based on the financial report for Jun 30, 2024, Cyclopharm Ltd's Total Receivables amounts to 8.3m AUD.

What is Cyclopharm Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
10%

Over the last year, the Total Receivables growth was -14%. The average annual Total Receivables growth rates for Cyclopharm Ltd have been 18% over the past three years , 19% over the past five years , and 10% over the past ten years .

Back to Top